fr 139317 has been researched along with dronabinol in 1 studies
| Studies (fr 139317) | Trials (fr 139317) | Recent Studies (post-2010) (fr 139317) | Studies (dronabinol) | Trials (dronabinol) | Recent Studies (post-2010) (dronabinol) |
|---|---|---|---|---|---|
| 219 | 0 | 8 | 8307 | 785 | 3094 |
| Protein | Taxonomy | fr 139317 (IC50) | dronabinol (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | 43.6 | |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.218 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 0.0028 | |
| Cannabinoid receptor 2 | Homo sapiens (human) | 0.0095 | |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.218 | |
| G-protein coupled receptor 55 | Homo sapiens (human) | 14.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kendall, DA; O'Sullivan, SE; Randall, MD | 1 |
1 other study(ies) available for fr 139317 and dronabinol
| Article | Year |
|---|---|
The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
Topics: Animals; Apamin; Arachidonic Acids; Azepines; Barium Compounds; Biological Factors; Calcium; Cannabinoid Receptor Modulators; Capsaicin; Charybdotoxin; Chlorides; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Endocannabinoids; Endothelium, Vascular; Female; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Pertussis Toxin; Piperidines; Polyunsaturated Alkamides; Potassium Channel Blockers; Potassium Channels; Pyrazoles; Rats; Rats, Wistar; Rimonabant; Vasodilation; Verapamil | 2005 |